FINGOLIMOD HYDROCHLORIDE | A207985 | GLENMARK PHARMACEUTICALS LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al 2 patentsANDA 207993, 210252, 207927, 207945, 207985, 207939, 207933, 208003, 207971, 207994Fingolimod | D. Del. | 2020-01-28 | Active | — |
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al 1 patentANDA 207991, 208004, 207983, 207979, 210252, 207940, 208000, 207927, 207945, 207941, 207985, 207939Fingolimod | D. Del. | 2018-07-16 | Terminated 2022-10-20 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.